Last reviewed · How we verify
NCT03859089: COST
Cannabis for Opioid Substitution Trial
trial testing Medical Cannabis in Pain Syndrome in 1,200 participants. Status unknown.
30 June 2019
Quick facts
| Lead sponsor | Cannabis Research Associates |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 1,200 |
| Start date | 10 October 2017 |
| Primary completion | 30 June 2019 |
| Estimated completion | 31 October 2019 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Medical Cannabis — full drug profile →
Conditions studied
- Pain Syndrome — all drugs for Pain Syndrome →
- Opioid Use — all drugs for Opioid Use →
- Cannabis Use — all drugs for Cannabis Use →
Sponsor
Cannabis Research Associates
Who can join
25 and older, any sex, with Pain Syndrome or Opioid Use. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to define common strains of cannabis that adult chronic cancer and non-cancer pain syndrome patients are using as a replacement for opioids (narcotics). Identified strains, if any, will then be tested via randomized controlled trials to support an application for a Health Canada Drug Identification Number.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03859089
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Medical Cannabis
Trials testing the same drug.
- NCT07374939 — Medical Cannabis for Nausea in Patients Receiving Moderately or Highly Emetogenic Chemotherapy · Phase 2 · not yet recruiting
- NCT06490445 — A Study of Medical Cannabis Aerosol Via the Fixed-dose Syqe Inhaler as an Add-on Treatment of Diabetic Peripheral Neurop · Phase 2 · recruiting
- NCT05863910 — Real World Evidence on the Use of Medical Cannabis in Pediatrics · recruiting
- NCT06217146 — A Medical Cannabis Oil for Treatment of Agitation and Disruptive Behaviors in Subjects With Dementia. · NA · terminated
- NCT04629716 — Reactions of Older Adults Driving After Cannabis Exposure · completed
Other recruiting trials for Pain Syndrome
Currently open trials in the same condition.
- NCT07421427 — Adding Amantadine or Duloxetine to Pregabalin on Occurrence of Post Mastectomy Pain Syndrome · NA · recruiting
- NCT06722014 — Integrating Pain-CBT Into an mHealth Analgesic Support Intervention for Patients With Chronic Pain From Advanced Cancers · NA · recruiting
- NCT06884852 — Ultrasound-guided Multilevel Erectorspinae Plane Block Versus Thoracic Epidural Analgesia for Prevention of Post Mastect · NA · recruiting
- NCT06704698 — Postoperative Analgesia Between Paravertebral Block and Epidural Block in Esophageal Surgery · NA · recruiting
- NCT05805696 — Treatment and Mapping of Impostor Phenomenon · NA · recruiting
Other Cannabis Research Associates trials
Trials by the same sponsor.
- NCT04878068 — Study to Evaluate the Performance of the Therma COVID-19 Rapid Antigen Test for Detection of SARS-CoV-2 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03859089 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cannabis Research Associates
- Last refreshed: 1 March 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03859089.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing